Follow The Filings

TEVA position history

The shares of Teva Pharmaceutical Industries (TEVA) that GLENVIEW CAPITAL MANAGEMENT, LLC reported in each quarter’s 13F.

Equity, SPONSORED ADS

Shares held by quarter

New Add Reduce Exit

  1. 2023 Q4: 1,604,633 shares, $17M, 0.36% of portfolio, New
  2. 2024 Q1: 7,501,284 shares, $106M, 1.9% of portfolio, Add +367.5%
  3. 2024 Q2: 9,157,641 shares, $149M, 2.9% of portfolio, Add +22.1%
  4. 2024 Q3: 8,456,324 shares, $152M, 2.9% of portfolio, Reduce −7.7%
  5. 2024 Q4: 8,456,324 shares, $186M, 4.7% of portfolio
  6. 2025 Q1: 14,778,641 shares, $227M, 5.6% of portfolio, Add +74.8%
  7. 2025 Q2: 15,824,223 shares, $265M, 7.4% of portfolio, Add +7.1%
  8. 2025 Q3: 16,692,680 shares, $337M, 7.5% of portfolio, Add +5.5%
  9. 2025 Q4: 16,720,209 shares, $522M, 10.6% of portfolio, Add +0.2%
  10. 2026 Q1: 6,660,220 shares, $201M, 5.0% of portfolio, Reduce −60.2%
  11. 2026 Q2: 5,081,091 shares, $172M, 3.1% of portfolio, Reduce −23.7%
  12. 2026 Q3: not held, Exit
Holdings date Value % of holdings Shares Filing date All 13F holders